Guardian Pharmacy Services, Inc.
For the period ended Mar 31, 2026. Filed May 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 6, 2026
GRDN$47.02+10.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
| (In thousands, except share amounts) | December 31, 2025 | March 31, 2026 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $65,619 | $64,893 |
| Accounts receivable, net | 101,614 | 111,704 |
| Inventories | 43,359 | 47,159 |
| Other current assets | 11,042 | 11,428 |
| Total current assets | 221,634 | 235,184 |
| Property and equipment, net | 55,522 | 56,620 |
| Intangible assets, net | 18,475 | 17,482 |
| Goodwill | 79,743 | 79,743 |
| Operating lease right-of-use assets | 34,649 | 34,268 |
| Deferred tax assets | 2,199 | 2,199 |
| Other assets | 436 | 1,445 |
| Total assets | $412,658 | $426,941 |
| Liabilities and equity | ||
| Current liabilities: | ||
| Accounts payable | $116,206 | $108,552 |
| Accrued compensation | 15,048 | 12,790 |
| Operating leases, current portion | 7,150 | 7,220 |
| Other current liabilities | 22,299 | 31,981 |
| Total current liabilities | 160,703 | 160,543 |
| Operating leases, net of current portion | 29,992 | 29,665 |
| Other liabilities | 4,039 | 4,309 |
| Total liabilities | $194,734 | $194,517 |
| Commitments and contingencies (see Note 5) | ||
| Equity: | ||
| Class A common stock - 700,000,000 shares authorized, par value $0.001; 36,253,744 and 49,781,181 shares issued and outstanding as of December 31, 2025 and March 31, 2026, respectively | 36 | 50 |
| Class B common stock - 100,000,000 shares authorized, par value $0.001; 27,066,890 and 13,539,453 shares issued and outstanding as of December 31, 2025 and March 31, 2026, respectively | 27 | 13 |
| Additional paid-in capital | 139,353 | 141,190 |
| Retained earnings | 66,343 | 79,638 |
| Non-controlling interests | 12,165 | 11,533 |
| Total equity | 217,924 | 232,424 |
| Total liabilities and equity | $412,658 | $426,941 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.